Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3.
Wagman, A.S., Boyce, R.S., Brown, S.P., Fang, E., Goff, D., Jansen, J.M., Le, V.P., Levine, B.H., Ng, S.C., Ni, Z.J., Nuss, J.M., Pfister, K.B., Ramurthy, S., Renhowe, P.A., Ring, D.B., Shu, W., Subramanian, S., Zhou, X.A., Shafer, C.M., Harrison, S.D., Johnson, K.W., Bussiere, D.E.(2017) J Med Chem 60: 8482-8514
- PubMed: 29016121 
- DOI: 10.1021/acs.jmedchem.7b00922
- Primary Citation of Related Structures:  
6B8J - PubMed Abstract: 
In an effort to identify new antidiabetic agents, we have discovered a novel family of (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine analogues which are inhibitors of human glycogen synthase kinase 3 (GSK3). We developed efficient synthetic routes to explore a wide variety of substitution patterns and convergently access a diverse array of analogues ...